Cytokines play pivotal roles in the pathophysiology of severe sepsis/septic shock, and continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF) removes cytokines efficiently and continuously, mainly through adsorption to a hemofilter membrane. The aim of this study was to investigate the clinical efficacy of enhanced intensity PMMA-CHDF in treating refractory septic shock.
Methods
Seventy-two septic shock patients admitted to the intensive care unit (ICU) underwent critical care including PMMA-CHDF. We employed enhanced intensity PMMA-CHDF to improve the cytokine removal rate by increasing the hemofilter membrane area in 10 refractory septic shock patients (enhanced intensity group, EI group; 2 extracorporeal CHDF circuits using the hemofilter with a larger membrane area of 2.1 m2). Other patients undergoing conventional PMMA-CHDF and matched for severity with the EI group, comprised a matched conventional group (MC group; using a PMMA membrane hemofilter with a membrane area of 1.0 m2; n=15). The case-control comparison was performed between the 2 groups.
Results
Enhanced intensity PMMA-CHDF significantly increased mean arterial pressure by 23.8% in 1 hour (p=0.037), decreased the blood lactate level by 28.6% in 12 hours (p=0.006), and reduced blood IL-6 level in 24 hours (p=0.005). The ICU survival rate in the EI group was significantly better than that in the MC group (60% vs. 13.3%, p=0.028).
Conclusion
Enhanced intensity PMMA-CHDF may improve hemodynamics and survival rate in patients with refractory septic shock.
VenkataramanR., SubramanianS., KellumJ.A.Clinical review: extracorporeal blood purification in severe sepsis.Crit Care.2003; 7(2): 139–145. Medline. doi: 10.1186/cc1889
5.
RoncoC., BonelloM., BordoniV.. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis.Blood Purif.2004; 22(1): 164–174. Medline. doi: 10.1159/000074937
6.
RoncoC., BellomoR., HomelP.. Effects of different doses in continuous veno-venous haemofiltration on out-comes of acute renal failure: a prospective randomised trial.Lancet.2000; 356(9223): 26–30. Medline. doi: 10.1016/S0140-6736(00)02430-2
CornejoR., DowneyP., CastroR.. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock.Intensive Care Med.2006; 32(5): 713–722. Medline. doi: 10.1007/s00134-006-0118-5
HirasawaH., OdaS., MatsudaK.Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock.Contrib Nephrol.2007; 156: 365–370. Medline. doi: 10.1159/000102127
11.
NakadaT.A., OdaS., MatsudaK.. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock.Mol Med.2008; 14(5-6): 257–263. Medline. doi: 10.2119/2007-00108. Nakada
12.
BoneR.C., BalkR.A., CerraF.B.. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest.1992; 101(6): 1644–1655. Medline. doi: 10.1378/chest.101.6.1644
13.
DellingerR.P., CarletJ.M., MasurH.. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Crit Care Med.2004; 32(3): 858–873. Medline. doi: 10.1097/01.CCM.0000117317.18092.E4
14.
RiversE., NguyenB., HavstadS.. Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl J Med.2001; 345(19): 1368–1377. Medline. doi: 10.1056/NEJMoa010307
15.
The Acute Respiratory Distress Syndrome Network.Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.N Engl J Med.2000; 342(18): 1301–1308. Medline. doi: 10.1056/NEJM200005043421801
16.
OdaS., HirasawaH., ShigaH., NakanishiK., MatsudaK., NakamuraM.Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis.Cytokine.2005; 29(4): 169–175. Medline. doi: 10.1016/j.cyto.2004.10.010
17.
VincentJ.L., de MendoncaA., CantraineF.. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on “Sepsis-Related Problems” of the European Society of Intensive Care Medicine.Crit Care Med.1998; 26(11): 1793–1800. Medline. doi: 10.1097/00003246-199811000-00016
18.
KnausW.A., DraperE.A., WagnerD.P., ZimmermanJ.E.APACHE II: a severity of disease classification system.Crit Care Med.1985; 13(10): 818–829. Medline. doi: 10.1097/00003246-198510000-00009
19.
KobayashiA., IwasakiY., KimuraY.. Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock.J Anesth.2010; 24(5): 709–715. Medline. doi: 10.1007/s00540-010-0986-2
20.
BellomoR., RoncoC., KellumJ.A.. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Crit Care.2004; 8(4): R204–R212.
21.
AntonelliM., LevyM., AndrewsP.J.. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27–28 April 2006.Intensive Care Med.2007; 33(4): 575–590. Medline. doi: 10.1007/s00134-007-0531-4
22.
LevrautJ., CiebieraJ.P., JambouP., IchaiC., LabibY., GrimaudD.Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients.Crit Care Med.1997; 25(1): 58–62. Medline. doi: 10.1097/00003246-199701000-00013
23.
McCormickJ.K., YarwoodJ.M., SchlievertP.M.Toxic shock syndrome and bacterial superantigens: an update.Annu Rev Microbiol.2001; 55: 77–104. Medline. doi: 10.1146/annurev.micro.55.1.77
24.
AloufJ.E., Muller-AloufH.Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.Int J Med Microbiol.2003; 292: 429–440. Medline. doi: 10.1078/1438-4221-00232
25.
WatanabeE., HirasawaH., OdaS., MatsudaK., HatanoM., TokuhisaT.Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms.Crit Care Med.2005; 33(1): 89–97. Medline. doi: 10.1097/01. CCM.0000150025.79100.7D
26.
CruzD.N., AntonelliM., FumagalliR.. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.JAMA.2009; 301(23): 2445–2452 Medline. doi: 10.1001/jama.2009.856
27.
RoncoC., KellumJ.A., BellomoR., HouseA.A.Potential interventions in sepsis-related acute kidney injury.Clin J Am Soc Nephrol.2008; 3(2): 531–544. Medline. doi: 10.2215/CJN.03830907
28.
KobeY., OdaS., MatsudaK., NakamuraM., HirasawaH.Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study.Blood Purif.2007; 25(5-6): 446–453. Medline. doi: 10.1159/000111568
29.
TaniguchiT., TakemotoY., TsudaK., InabaH., YamamotoK.Effects of post-treatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats.Blood Purif.2006; 24(5-6): 460–464. Medline. doi: 10.1159/000095554
30.
HaaseM., SilvesterW., UchinoS.. A pilot study of highadsorption hemofiltration in human septic shock.Int J Artif Organs.2007; 30(2): 108–117.
